Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis

by | Jul 1, 2026 | Clinical Trials | 0 comments

​ Conditions: Acute Myeloid Leukemia (AML)

Sponsors: The First Affiliated Hospital of Soochow University

Recruiting Conditions: Acute Myeloid Leukemia (AML)
Sponsors: The First Affiliated Hospital of Soochow University
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *